Effectieve immunotherapie tegen borstkanker KWF Kankerbestrijding


Karin De Visser, Working On Threat Famous artists, Artist at work, Studio

Karin E. de Visser Nature Reviews Cancer 16 , 431-446 ( 2016) Cite this article 34k Accesses 1045 Citations 21 Altmetric Metrics Key Points In patients with solid cancers, neutrophils expand.


exto.nl City Blues van Karin de Visser

Karin E. de Visser Johanna A. Joyce DOI: https://doi.org/10.1016/j.ccell.2023.02.016 The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth Summary Cancers represent complex ecosystems comprising tumor cells and a multitude of non-cancerous cells, embedded in an altered extracellular matrix.


Effectieve immunotherapie tegen borstkanker KWF Kankerbestrijding

Karin de Visser @deVisserKarin Tumor Immunologist @NKI_nl @oncodeinstitute interested in crosstalk between the immune system and breast cancer, metastasis, myeloid and adaptive immune cells Amsterdam, The Netherlandsnki.nl/research/resea… Joined December 2022 40Following 397Followers Tweets Tweets & replies Media Likes Karin de Visser's Tweets


Karin de Visser Twentyfour Seven

Bekijk het profiel van Karin de Visser op LinkedIn, de grootste professionele community ter wereld. Karin heeft 7 functies op zijn of haar profiel. Bekijk het volledige profiel op LinkedIn om de connecties van Karin en vacatures bij vergelijkbare bedrijven te zien.


Karin de Visser, kunstenaar van de maand augustus 2021 » Art & Jazz

Seth B Coffelt 1 , Max D Wellenstein 1 , Karin E de Visser 1 Affiliation 1 Division of Immunology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. PMID: 27282249 DOI: 10.1038/nrc.2016.52 Abstract Neutrophils are indispensable antagonists of microbial infection and facilitators of wound healing..


Rotterdam Contemporary Art Fair 2017

615 Chestnut St., 17th Floor Philadelphia, PA 19106-4404 USA Telephone: Email: Karin E. de Visser is a member of the Tumor Microenvironment Working Group Steering Committee.


Projectleider Karin Visser vertelt hoe de regio Amsterdam de subsidieaanvraag aanpakt Babyconnect

Karin E. de Visser Nature Reviews Immunology 20 , 483-497 ( 2020) Cite this article 20k Accesses 205 Citations 108 Altmetric Metrics Abstract Metastatic disease is responsible for.


Birgit Speulman Karin de Visser Birgit Speulman

Karin E. de Visser's research while affiliated with Netherlands Cancer Institute and other places Overview What is this page? This page lists the scientific contributions of an author, who.


De Visser, Karin, PhD TRR332 neutrophils

In February Karin de Visser received a VICI grant from NWO to investigate how genetic changes in breast cancer cells influence the immune system of patients. De Visser's research group is also affiliated with the Oncode Institute.


Karin de Visser YouTube

KARIN DE VISSER OUR RESOURCES Resources. Our team has developed a preclinical mouse model of invasive lobular breast cancer metastasis. We used this model to unravel mammary tumor-induced pro-metastatic inflammation (IL-17-producing γδ T cells and.


Karin Karin Visser

KARIN DE VISSER OUR RESEARCH Inflammation and cancer. Metastasis formation and unresponsiveness to conventional therapies are the challenges in cancer patient care that urgently need solutions. The overall goal of our research is to gain novel mechanistic insights into how the immune system influences these processes, with a primary focus on.


exto.nl Encagement van Karin de Visser

Karin de Visser Inflammation and cancer Metastasis formation and unresponsiveness to conventional therapies are the challenges in cancer patient care that urgently need solutions. The overall goal of our research is to gain novel mechanistic insights into how the immune system influences these processes, with a primary focus on breast cancer.


Inaugural lecture Karin de Visser Oncode Institute

KARIN DE VISSER Karin de Visser Group leader +31 20 512 6104 [email protected] Prof. dr. Karin E. de Visser obtained her PhD at the Division of Immunology at the Netherlands Cancer Institute in Amsterdam in the field of tumor immunotherapy.


Karin Visser directeur Toezicht en Opsporing bij ILT Nieuwsbericht Algemene Bestuursdienst

Seth B Coffelt 1 , Karin E de Visser 1 Affiliation 1 Division of Immunology, Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands. PMID: 24572360 DOI: 10.1038/nature13062 No abstract available. Publication types Comment MeSH terms.


Karin de Visser Suspension

Hannah Garner 1 , Karin E de Visser 2 3 Affiliations 1 Division of Tumour Biology & Immunology, Oncode Institute, Netherlands Cancer Institute, Amsterdam, Netherlands.. Leiden University Medical Centre, Leiden, Netherlands. [email protected]. PMID: 32024984 DOI: 10.1038/s41577-019-0271-z Abstract.


Karin de Visser, kunstenaar van de maand augustus 2021 » Art & Jazz

Karina Elizabeth de Visser (Karin de Visser, 1975), [1] also named "Karin E. de Visser", is a researcher at the Netherlands Cancer Institute. Her research considers metastatic formation and how the immune system influences how people respond to cancer treatment. Early life and education